Wang Zhen, Fan Zhao-Qing, Wang Li-Ze, Cao Kun, Long Rong, Luo Yao, Li Xiao-Ting, You Liang, Li Qing-Yang, Sun Ying-Shi
Department of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fu Cheng Rd, Hai Dian District, Beijing, 100142, China.
Breast Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, No. 52 Fu Cheng Rd, Hai Dian District, Beijing, 100142, China.
BMC Med Imaging. 2025 Jul 1;25(1):233. doi: 10.1186/s12880-025-01799-7.
BACKGROUND: A proportion of breast patients achieve axillary pathological complete response (pCR) following NAC. However, few studies have investigated the potential of quantitative parameters derived from dual-energy CT (DECT) for predicting axillary lymph node (ALN) downstaging after NAC. METHODS: This study included a prospective training and retrospective validation cohort from December 2019 to June 2022. Both groups enrolled invasive breast cancer with biopsy-proved metastatic ALNs who underwent contrast-enhanced DECT and NAC followed by surgery. A metastatic ALN, named target lymph node (TLN), was marked with metal clip at baseline. Quantitative DECT parameters and size of TLN, and clinical information were compared between pCR and non-pCR node group referring to postoperative pathology. Three predictive models, clinical, quantitative CT, and combinational models, were built by logistic regression and nomogram was drawn accordingly. The performance was evaluated by the receiver operator characteristic curve and clinical usefulness was assessed by decision curve analysis. RESULTS: A total of 75 and 53 patients were included in training and validation cohort respectively. Of them, 34 (45.3%) and 22 (41.5%) patients achieved nodal pCR in the two sets. Multivariable analyses revealed that negative estrogen receptor expression, parenchyma thickness and the iodine concentration of TLN at post-NAC CT were independently predictive factors for pCR. The combinational model showed discriminatory power than the single clinical model (AUC, 0.724; p = 0.003) and quantitative CT model (AUC, 0.728; p = 0.030) with AUC of 0.847 and 0.828 in training and validation cohort. It provided enhanced net benefits within a wide range of threshold probabilities. CONCLUSION: Quantitative DECT parameters can be used to evaluate axillary nodal status after NAC and guide personalized treatment strategies.
背景:一部分乳腺癌患者在新辅助化疗(NAC)后实现腋窝病理完全缓解(pCR)。然而,很少有研究探讨双能CT(DECT)衍生的定量参数预测NAC后腋窝淋巴结(ALN)降期的潜力。 方法:本研究纳入了2019年12月至2022年6月的前瞻性训练队列和回顾性验证队列。两组均纳入经活检证实有转移性ALN的浸润性乳腺癌患者,这些患者接受了对比增强DECT和NAC,随后进行手术。在基线时用金属夹标记一个转移性ALN,称为靶淋巴结(TLN)。根据术后病理,比较pCR组和非pCR组TLN的DECT定量参数、大小及临床信息。通过逻辑回归建立了三种预测模型,即临床模型、定量CT模型和联合模型,并据此绘制列线图。通过受试者工作特征曲线评估模型性能,通过决策曲线分析评估临床实用性。 结果:训练队列和验证队列分别纳入75例和53例患者。其中,两组分别有34例(45.3%)和22例(41.5%)患者实现淋巴结pCR。多变量分析显示,雌激素受体阴性表达、NAC后CT上TLN的实质厚度和碘浓度是pCR的独立预测因素。联合模型在训练队列和验证队列中的曲线下面积(AUC)分别为0.847和0.828,显示出比单一临床模型(AUC,0.724;p = 0.003)和定量CT模型(AUC,0.728;p = 0.030)更强的鉴别能力。在广泛的阈值概率范围内,联合模型提供了更高的净效益。 结论:DECT定量参数可用于评估NAC后腋窝淋巴结状态并指导个性化治疗策略。
J Coll Physicians Surg Pak. 2025-3
Health Technol Assess. 2006-9